Revenue increased 33.9%
Revenue changed +33.9% from the comparable as-filed period.
$5.3B→$7.1B1 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +33.9% from the comparable as-filed period.
Operating income changed +43.5% from the comparable as-filed period.
Inventory / revenue changed -2243 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.